Ensuring incentives for innovation and access to medicines: The balance struck in the Trans-Pacific Partnership Agreement on intellectual property (patent and regulatory data) protection for pharmaceutical products

The United Nations Economic Commission for Latin America and the Caribbean (ECLAC) commissioned this study to analyze the implications of the balance struck under the Trans-Pacific Partnership Agreement (TPPA) between the right to health and access to next-generation medicines on the one hand, and o...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Plank-Brumback, Rosine M.
Formato:	Texto
Lenguaje:	English
Publicado:	ECLAC 2016
Materias:	ACUERDOS ECONOMICOS NEGOCIACIONES COMERCIALES COMERCIO INTERNACIONAL PROPIEDAD INTELECTUAL PRODUCTOS FARMACEUTICOS POLITICA COMERCIAL INNOVACIONES ECONOMIC AGREEMENTS TRADE NEGOTIATIONS INTERNATIONAL TRADE INTELLECTUAL PROPERTY PHARMACEUTICALS TRADE POLICY INNOVATIONS
Acceso en línea:	http://hdl.handle.net/11362/40723
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai-11362-40723
record_format	dspace
spelling	oai-11362-407232020-11-25T22:58:09Z Ensuring incentives for innovation and access to medicines: The balance struck in the Trans-Pacific Partnership Agreement on intellectual property (patent and regulatory data) protection for pharmaceutical products Plank-Brumback, Rosine M. ACUERDOS ECONOMICOS NEGOCIACIONES COMERCIALES COMERCIO INTERNACIONAL PROPIEDAD INTELECTUAL PRODUCTOS FARMACEUTICOS POLITICA COMERCIAL INNOVACIONES ECONOMIC AGREEMENTS TRADE NEGOTIATIONS INTERNATIONAL TRADE INTELLECTUAL PROPERTY PHARMACEUTICALS TRADE POLICY INNOVATIONS The United Nations Economic Commission for Latin America and the Caribbean (ECLAC) commissioned this study to analyze the implications of the balance struck under the Trans-Pacific Partnership Agreement (TPPA) between the right to health and access to next-generation medicines on the one hand, and on the other, the private right to intellectual property protection and the need to maintain profit-earning incentives to spur innovation and research and development. The study focuses on the patent and data-related intellectual property protection provisions of the TPPA, specifically regarding pharmaceutical (small-molecule and biologic ) products, including on patent duration, linkage and term extensions as well as clinical test data protection and market exclusivity. The study considers the position of the United States in this respect, as it has been and remains the world’s principal demandeur for high intellectual property rights (IPR) standards in trade agreements, including the TPPA. Introduction .-- I. Multilateral trade rules for IPRs on pharmaceutical products .-- II. The U.S. approach to intellectual property protection on pharmaceutical products and the factors driving it .-- III. Key trends in the global and regional pharmaceutical industry .-- IV. Key TPPA provisions affecting pharmaceutical products .-- V. Conclusions on striking the appropriate balance between ensuring incentives for innovation and access to medicine. 2016-11-08T14:15:40Z 2016-11-08T14:15:40Z 2016-10-31 Texto Documento Completo http://hdl.handle.net/11362/40723 LC/WAS/W.8 LC/W.720 en .pdf application/pdf AMERICA LATINA Y EL CARIBE LATIN AMERICA AND THE CARIBBEAN ECLAC
institution	Cepal
collection	Cepal
language	English
topic	ACUERDOS ECONOMICOS NEGOCIACIONES COMERCIALES COMERCIO INTERNACIONAL PROPIEDAD INTELECTUAL PRODUCTOS FARMACEUTICOS POLITICA COMERCIAL INNOVACIONES ECONOMIC AGREEMENTS TRADE NEGOTIATIONS INTERNATIONAL TRADE INTELLECTUAL PROPERTY PHARMACEUTICALS TRADE POLICY INNOVATIONS
spellingShingle	ACUERDOS ECONOMICOS NEGOCIACIONES COMERCIALES COMERCIO INTERNACIONAL PROPIEDAD INTELECTUAL PRODUCTOS FARMACEUTICOS POLITICA COMERCIAL INNOVACIONES ECONOMIC AGREEMENTS TRADE NEGOTIATIONS INTERNATIONAL TRADE INTELLECTUAL PROPERTY PHARMACEUTICALS TRADE POLICY INNOVATIONS Plank-Brumback, Rosine M. Ensuring incentives for innovation and access to medicines: The balance struck in the Trans-Pacific Partnership Agreement on intellectual property (patent and regulatory data) protection for pharmaceutical products
description	The United Nations Economic Commission for Latin America and the Caribbean (ECLAC) commissioned this study to analyze the implications of the balance struck under the Trans-Pacific Partnership Agreement (TPPA) between the right to health and access to next-generation medicines on the one hand, and on the other, the private right to intellectual property protection and the need to maintain profit-earning incentives to spur innovation and research and development. The study focuses on the patent and data-related intellectual property protection provisions of the TPPA, specifically regarding pharmaceutical (small-molecule and biologic ) products, including on patent duration, linkage and term extensions as well as clinical test data protection and market exclusivity. The study considers the position of the United States in this respect, as it has been and remains the world’s principal demandeur for high intellectual property rights (IPR) standards in trade agreements, including the TPPA.
format	Texto
author	Plank-Brumback, Rosine M.
author_facet	Plank-Brumback, Rosine M.
author_sort	Plank-Brumback, Rosine M.
title	Ensuring incentives for innovation and access to medicines: The balance struck in the Trans-Pacific Partnership Agreement on intellectual property (patent and regulatory data) protection for pharmaceutical products
title_short	Ensuring incentives for innovation and access to medicines: The balance struck in the Trans-Pacific Partnership Agreement on intellectual property (patent and regulatory data) protection for pharmaceutical products
title_full	Ensuring incentives for innovation and access to medicines: The balance struck in the Trans-Pacific Partnership Agreement on intellectual property (patent and regulatory data) protection for pharmaceutical products
title_fullStr	Ensuring incentives for innovation and access to medicines: The balance struck in the Trans-Pacific Partnership Agreement on intellectual property (patent and regulatory data) protection for pharmaceutical products
title_full_unstemmed	Ensuring incentives for innovation and access to medicines: The balance struck in the Trans-Pacific Partnership Agreement on intellectual property (patent and regulatory data) protection for pharmaceutical products
title_sort	ensuring incentives for innovation and access to medicines: the balance struck in the trans-pacific partnership agreement on intellectual property (patent and regulatory data) protection for pharmaceutical products
publisher	ECLAC
publishDate	2016
url	http://hdl.handle.net/11362/40723
work_keys_str_mv	AT plankbrumbackrosinem ensuringincentivesforinnovationandaccesstomedicinesthebalancestruckinthetranspacificpartnershipagreementonintellectualpropertypatentandregulatorydataprotectionforpharmaceuticalproducts
_version_	1718434135278616576

Ensuring incentives for innovation and access to medicines: The balance struck in the Trans-Pacific Partnership Agreement on intellectual property (patent and regulatory data) protection for pharmaceutical products

Ejemplares similares